The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2024 | Unmet needs in LR-MDS: managing anemia
Matteo Della Porta, MD, IRCCS Humanitas Research Hospital, Milan, Italy, discusses unmet needs that remain in the treatment of lower-risk myelodysplastic syndromes (LR-MDS). He highlights the need for better treatment of anemia and restoration of effective erythropoiesis, especially after failure of erythropoiesis-stimulating agents (ESAs). This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
